Clinical trial • Phase III • Psychiatry
Clinical trial in Depression
Phase III trial for Depression. Randomised, placebo (dose/schedule not specified)-controlled, crossover. 70 participants.
Overview
- Trial Therapeutic Area
- Psychiatry
- Trial Disease
- Depression
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 26-09-2024
- First CTIS Authorization Date
- 30-10-2024
Trial design
Randomised, placebo (dose/schedule not specified)-controlled, crossover Phase III trial across 1 site in Austria.
- Randomised
- Yes
- Comparator
- Placebo (dose/schedule not specified)
- Crossover
- Yes
- Target Sample Size
- 70
Recruitment
- Planned Sample Size
- 70
- Recruitment Window Months
- 12
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 70
Austria
- Earliest CTIS Part Ii Submission Date
- 09-10-2024
- Latest Decision Or Authorization Date
- 30-10-2024
- Processing Time Days
- 21
- Number Of Sites
- 1
- Number Of Participants
- 70
Sites
- Site Name
- Medical University Of Vienna - Waehringer Guertel 18-20
- Department Name
- Department of Psychiatry and Psychotherapy, Division of General Psychiatry
- Principal Investigator Name
- Marie Spies
- Principal Investigator Email
- marie.spies@meduniwien.ac.at
- Contact Person Name
- Marie Spies
- Contact Person Email
- marie.spies@meduniwien.ac.at
- Number Of Participants
- 70
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Related trials
Other published trials that may interest you.